News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,475 Results
Type
Article (42208)
Company Profile (260)
Press Release (667007)
Section
Business (207448)
Career Advice (2542)
Deals (35924)
Drug Delivery (101)
Drug Development (81516)
Employer Resources (178)
FDA (16393)
Job Trends (15075)
News (350449)
Policy (33290)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2635)
Accelerated approval (3)
Adcomms (23)
Allergies (81)
Alliances (50375)
ALS (84)
Alzheimer's disease (1376)
Antibody-drug conjugate (ADC) (109)
Approvals (16384)
Artificial intelligence (240)
Autoimmune disease (14)
Automation (14)
Bankruptcy (367)
Best Places to Work (11783)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (180)
Bladder cancer (58)
Brain cancer (24)
Breast cancer (248)
Cancer (2012)
Cardiovascular disease (163)
Career advice (2107)
Career pathing (31)
CAR-T (139)
Cell therapy (396)
Cervical cancer (19)
Clinical research (66026)
Collaboration (769)
Compensation (449)
Complete response letters (20)
COVID-19 (2648)
CRISPR (37)
C-suite (214)
Cystic fibrosis (99)
Data (1955)
Decentralized trials (2)
Denatured (17)
Depression (40)
Diabetes (251)
Diagnostics (6729)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (111)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (87)
Earnings (87426)
Editorial (34)
Employer branding (21)
Employer resources (151)
Events (113765)
Executive appointments (647)
FDA (17504)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (694)
Gene editing (98)
Generative AI (23)
Gene therapy (278)
GLP-1 (700)
Government (4558)
Grass and pollen (4)
Guidances (48)
Healthcare (19203)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (104)
Indications (26)
Infectious disease (2780)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (47)
Intellectual property (86)
Interviews (521)
IPO (16683)
IRA (43)
Job creations (3719)
Job search strategy (1720)
Kidney cancer (9)
Labor market (34)
Layoffs (462)
Leadership (16)
Legal (8079)
Liver cancer (72)
Lung cancer (295)
Lymphoma (133)
Machine learning (4)
Management (59)
Manufacturing (273)
MASH (60)
Medical device (13525)
Medtech (13530)
Mergers & acquisitions (19706)
Metabolic disorders (642)
Multiple sclerosis (71)
NASH (18)
Neurodegenerative disease (77)
Neuropsychiatric disorders (25)
Neuroscience (1855)
NextGen: Class of 2025 (6643)
Non-profit (4582)
Northern California (2425)
Now hiring (37)
Obesity (346)
Opinion (218)
Ovarian cancer (72)
Pain (78)
Pancreatic cancer (77)
Parkinson's disease (133)
Partnered (20)
Patents (206)
Patient recruitment (94)
Peanut (47)
People (57923)
Pharmaceutical (64)
Pharmacy benefit managers (19)
Phase I (20544)
Phase II (29060)
Phase III (21697)
Pipeline (1028)
Podcasts (50)
Policy (113)
Postmarket research (2594)
Preclinical (8707)
Press Release (66)
Prostate cancer (95)
Psychedelics (31)
Radiopharmaceuticals (252)
Rare diseases (359)
Real estate (6005)
Recruiting (69)
Regulatory (22612)
Reports (46)
Research institute (2391)
Resumes & cover letters (409)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (66)
Series A (121)
Series B (78)
Service/supplier (12)
Sickle cell disease (51)
Southern California (2114)
Special edition (15)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3663)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (30)
United States (21311)
Vaccines (669)
Venture capitalists (38)
Webinars (12)
Weight loss (232)
Women's health (33)
Worklife (17)
Date
Today (241)
Last 7 days (751)
Last 30 days (2769)
Last 365 days (34012)
2025 (8063)
2024 (35643)
2023 (40556)
2022 (51705)
2021 (56305)
2020 (54852)
2019 (47351)
2018 (35751)
2017 (32729)
2016 (32326)
2015 (38377)
2014 (32010)
2013 (27156)
2012 (29353)
2011 (30031)
2010 (27985)
Location
Africa (789)
Alabama (49)
Alaska (7)
Arizona (226)
Arkansas (13)
Asia (38789)
Australia (6399)
California (5550)
Canada (1875)
China (477)
Colorado (247)
Connecticut (258)
Delaware (127)
Europe (83926)
Florida (820)
Georgia (200)
Idaho (57)
Illinois (504)
India (23)
Indiana (295)
Iowa (9)
Japan (143)
Kansas (101)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (835)
Massachusetts (4189)
Michigan (209)
Minnesota (378)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (65)
New Jersey (1580)
New Mexico (30)
New York (1592)
North Carolina (956)
North Dakota (7)
Northern California (2425)
Ohio (193)
Oklahoma (14)
Oregon (33)
Pennsylvania (1253)
Puerto Rico (9)
Rhode Island (26)
South America (1160)
South Carolina (18)
South Dakota (1)
Southern California (2114)
Tennessee (92)
Texas (833)
Utah (167)
Virginia (128)
Washington D.C. (57)
Washington State (522)
West Virginia (3)
Wisconsin (56)
709,475 Results for "quest diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025
April 1, 2025
·
1 min read
Press Releases
GRAIL and Quest Diagnostics Provide GRAIL’s Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
February 13, 2025
·
9 min read
Press Releases
Quest Diagnostics to Host Investor Day on March 19, 2025
February 14, 2025
·
1 min read
Pharm Country
Quest Diagnostics Releases 2023 Corporate Responsibility Report
Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.
June 27, 2024
·
3 min read
Press Releases
Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day
March 19, 2025
·
8 min read
Press Releases
Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals
January 27, 2025
·
2 min read
Deals
Quest Diagnostics to Acquire Select Lab Assets from Allina Health
Quest Diagnostics and Allina Health announced a definitive agreement for Quest to acquire select laboratory assets from Allina Health, with the goal to improve access to and the affordability of innovative laboratory services across Minnesota and western Wisconsin.
June 26, 2024
·
2 min read
Business
Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2024 financial results on Tuesday, July 23, 2024, before the market opens.
June 19, 2024
·
1 min read
Business
Quest Diagnostics Declares Quarterly Cash Dividend - May 15, 2024
Quest Diagnostics, a leader in diagnostic information services, announced that its Board of Directors declared a quarterly cash dividend of $0.75 per share, payable on July 22, 2024 to shareholders of record of Quest Diagnostics common stock on July 8, 2024.
May 15, 2024
·
1 min read
Press Releases
Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share
January 30, 2025
·
19 min read
1 of 70,948
Next